Headlines
-
Concern over CM ad changes
Monday | Jan 22 2018THE Federal government has been accused of attempting to bypass a Senate Committee review of proposed changes to advertising of complementary medicines, on the basis that the Therapeutic Goods Amendment Bill is "non-controversial".
-
S3 advertising permitted
Friday | Jan 19 2018THE Therapeutic Goods Administration has confirmed that the advertising of Schedule 3 (Pharmacist Only) medicines is to be allowed, along with the implementation of a more timely "switch" process facilitating rescheduling of Schedule 4 medicines to S3 and/or S2.
-
Codeine story ‘misleading’
Friday | Jan 19 2018WHILE the rescheduling of products containing codeine has been based mainly on the fact that codeine can cause dependence, and its misuse has led to addiction and even death, it is "misleading" to argue that withdrawing the products from OTC sale will reduce codeine use, according to University of Sydney Honorary Professor of Pharmacology Peter Carroll (pictured).
-
SHPA affirms codeine move
Thursday | Jan 18 2018THE Society of Hospital Pharmacists of Australia has recommitted its support for the rescheduling of OTC codeine products, which will become prescription only from 01 Feb 2018.
-
PSA seals diabetes deal
Wednesday | Jan 17 2018THE Pharmaceutical Society of Australia (PSA) has signed a new Memorandum of Understanding with the Australian Diabetes Educators Association (ADEA).
-
E-cigarette research boost
Tuesday | Jan 16 2018IN WHAT could prove to be a game-changer for the marketing of e-cigarettes, or vaping devices, various experts from the EU and UK have argued that a switch policy to move tobacco smokers across to e-cigarettes would be pro-health.
-
Fred IT links with AMH
Tuesday | Jan 16 2018FRED IT Group and the Australian Medicines Handbook have announced a partnership which will provide users of the cloud-based solution Fred NXT system with direct access to the Australian Medicines Handbook (AMH) medicines information.
-
GSK joins Click & Collect
Monday | Jan 15 2018GLAXOSMITHKLINE'S GSK Consumer Healthcare has confirmed its participation in the Pharmacy Guild's 'Click and Collect' program, as part of an overarching strategy to deliver a digital transformation program for community pharmacy in Australia.
-
Res-care meds simplified
Friday | Jan 12 2018WEBSTERCARE has announced changes to its RxMedChart process, claiming the new system can "reduce time spent on administration by doctors in NSW aged care facilities by 60%".
-
Medlab cannabis all-clear
Thursday | Jan 11 2018ASX-LISTED Medlab Clinical has received its license from the Victorian Government to sell or supply Schedule 8 or Schedule 9 Drugs in the form of cannabis and its derivatives, namely NanaBis (CBD:THC) and NanaBidial (CBD).